RDY: Summary for DR. REDDY'S LAB LTD - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Tuesday, November 24, 2009, 3:34am EST - Canadian Markets open in 5 hours and 56 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Dr. Reddy's Laboratories Ltd. (RDY)

On Nov 23: 24.12 USD 0.00 (0.00%)

MORE ON RDY

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

DR. REDDY'S LAB LTD (NYSE:RDY) Delayed quote data

Last Trade:	24.12 USD
Trade Time:	Nov 23
Change:	0.00 (0.00%)
Prev Close:	24.12
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	19.00

Day's Range:	N/A - N/A
52wk Range:	7.27 - 24.76
Volume:	0
Avg Vol (3m):	428,851
Market Cap:	4.07B
P/E (ttm):	23.19
EPS (ttm):	1.04
Div & Yield:	0.13 (0.54%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add RDY to Portfolio

Download Data

HEADLINES

•	Here's Where to Invest in India
	at Motley Fool (Mon 3:02pm)

•	The Best Way to Play India Now
	at Motley Fool (Mon 1:44pm)

•	It's Time to Invest in India
	at Motley Fool (Fri, Nov 20)

•	Now Is the Time to Buy Risk
	at Motley Fool (Fri, Nov 20)

•	The Life-and-Death Situation That Isn't
	at Motley Fool (Thu, Nov 12)

•	GlaxoSmithKline Reports Higher Revs
	Zacks.com (Thu, Nov 12)

•	Today's 5-Star Movers
	at Motley Fool (Wed, Nov 11)

•	Is Dr. Reddy's Laboratories Ready to Run?
	at Seeking Alpha (Tue, Nov 10)

•	Indian Pharmaceutical Stock Picks From Citi Investment Research: The Sub Continent Goes Global WIth Drug Manufacturing Partnerships
	Wall Street Transcript (Thu, Nov 5)

•	Dr. Reddy's Laboratories: Showing Promising Growth
	at Seeking Alpha (Thu, Nov 5)

•	The Complete List of Indian ADRs
	at Seeking Alpha (Mon, Nov 2)

•	2 Stocks Hitting High Notes
	at Motley Fool (Fri, Oct 30)

•	UPDATE - Sun Pharma Q2 net falls on US unit woes, Cipla soars
	at Reuters (Wed, Oct 28)

•	Dr. Reddy's upgraded by Credit Suisse
	Briefing.com (Mon, Oct 26)

More Headlines for RDY...

ANALYST

EPS Est (next year) (Mar-08) :	0.71
EPS Est (in 2 years) (Mar-09) :	1.11
Avg Rec (current)*:	3.0
PEG Ratio:	1.35

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as a pharmaceutical company. It focuses on formulations, active pharmaceutical ingredients and intermediates, generic drugs, critical care products, biotechnology products,...

Full Company Profile

Add to Portfolio

Email to a Friend

•